Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Sahlgrenska University Hospital · NewYork–Presbyterian Hospital · +13 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
5,415
total citations
- FWCI
- 302.91
- Percentile
- 100%
- References
- 29
Citations per year
Authors
15Topics & keywords
Topics
Keywords
- Atenolol
- Medicine
- Losartan
- Blood pressure
- Myocardial infarction
- Stroke (engine)
- Cardiology
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.